Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZapVir is a consumer health and pharmaceutical company focused on the manufacture, marketing, and sale of over-the-counter (OTC) antiseptic and homeopathic products. The company's flagship product line, SinoFresh, includes homeopathic antiseptic nasal sprays, throat sprays, and foaming hand sanitizers designed to stimulate the body's natural defenses against airborne germs, viruses, bacteria, and allergens. ZapVir's products utilize antiseptic formulations, including benzalkonium chloride and natural botanical extracts like peppermint and eucalyptus oils, to provide non-habit-forming sinus and nasal relief. While the company previously planned a merger with Suggestion Box, Inc. (SGTB) to transition into a public entity, SGTB ultimately pivoted to artificial intelligence and robotics, leaving ZapVir as an active private operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZapVir.